Pharma stocks rise on perceived regulatory stability

Industry leaders anticipate a smooth confirmation process, reducing uncertainty. The S&P Pharmaceuticals Index is projected to gain 3-5% within 30 days of the nomination announcement.

Implied probability (Yes)

60%